ZENITH HEALTH CARE LTD.

Zenith Healthcare Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The specific date for the board meeting to consider these financial results will be communicated later. This measure is in line with the company's code of conduct and SEBI regulations to prevent insider trading.

Zenith Healthcare Ltd. has appointed Mr. Tanaykumar Mohta as the Internal Auditor for the financial year 2026-27, as approved by the Board of Directors in their meeting held on May 29, 2026. Mr. Mohta is a Chartered Accountant with expertise in direct and indirect taxation, internal and bank audits, financial management, and business structuring.

Zenith Healthcare Ltd. has appointed Akshit Mahendra Raycha as the Joint Managing Director, effective May 29, 2026, for the financial year 2026-27. Mr. Raycha, son of CMD Mahendra C. Raycha and Director Neela M. Raycha, brings extensive management experience, including export business and retail industry expertise. His remuneration includes a monthly salary of up to ₹2,00,000 with an annual increase of ₹9,00,000, totaling ₹24,00,000 per annum, along with other perquisites. The appointment has been approved by the Nomination and Remuneration Committee and the Board of Directors, pending shareholder approval at the next AGM. His term of office is from May 29, 2026, to April 28, 2029.

Zenith Healthcare Ltd's board meeting on May 29, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The board also appointed M/s. Mohta Khetawat & Co. as Internal Auditor for FY 2026-27 and re-appointed Mr. Akshit Mahendra Raycha as Joint Managing Director for 3 years, subject to shareholder approval. The board authorized Mr. Mahendra C Raycha to fix the AGM date and related matters. The auditors, Doshi Doshi & Co., issued an unmodified opinion on the financial results.

Zenith Healthcare Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the fourth quarter and year ended March 31, 2026. The meeting will also cover various agenda items, including director disclosures, appointment of internal financial auditors, and related party transactions. The trading window for dealing in the company's securities remains closed until 48 hours after the declaration of the financial results.

Zenith Healthcare Ltd. has announced the closure of its trading window for dealing in the securities of the company. The closure will be in effect from 1st April 2026 till the end of 48 hours after the announcement of audited financial results for the quarter and year ending on March 31, 2026. The date of the Board Meeting for the consideration and declaration of financial results for the year ended 31st March, 2026 will be intimated later.

Zenith Healthcare Ltd has announced its un-audited financial results for the quarter ended on 31st December 2025. The total income for the quarter stands at INR 252.5 lacs, with a net profit of INR 539.22 lacs. The company operates in the Pharmaceuticals Trading segment. The financial results have been reviewed by the Board of Directors and the Statutory Auditors.

Zenith Healthcare Ltd, a Pharmaceuticals Trading company, has reported its financial results for the quarter and year ended 31st December, 2025. The company's revenue from operations stands at 1,132.97 lacs, with a net profit of 406.79 lacs for the quarter. The total income for the year is 1,148.19 lacs, with a net profit of 23.22 lacs. The EPS (Basic and Diluted) for the year is 1.20. The financial results have been reviewed by the Board of Directors and the Statutory Auditors.

Zenith Healthcare Ltd has announced a Board Meeting on February 12, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended on December 31, 2025. The meeting will be held at the company's registered office in Ahmedabad. The trading window for dealing in securities of the company will remain closed till 48 hours after the declaration of financial results.

Zenith Healthcare Ltd has announced the closure of its trading window in accordance with the Company's Code of Conduct and SEBI regulations. The trading window will remain closed from Thursday, January 01, 2026 till the end of 48 hours after the announcement / declaration of unaudited financial results for the quarter ending on 31st December, 2025. The date of the Board Meeting for consideration and declaration of the Financial Results for the Quarter ended on 31st December, 2025 is yet to be intimated.